Imed Infinity Medical LP (XTAE:IMED) EBIT: ₪ Mil (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTAE:IMED Imed Infinity Medical LP XTAE:IMED
18 GF Score
Price ₪0.89
! 2 Warning Signs
View Full Analysis

What is Imed Infinity Medical LP EBIT?

Imed Infinity Medical LP XTAE:IMED 18 EBIT is ₪ Mil as of . 20. GuruFocus rates XTAE:IMED with a GF Score™ of 18/100. The stock has 2 warning signs investors should review.

Imed Infinity Medical LP's earnings before interest and taxes (EBIT) for the six months ended in . 20 was ₪0.00 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

Imed Infinity Medical LP  (XTAE:IMED) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Imed Infinity Medical LP's annualized ROC % for the quarter that ended in . 20 is calculated as:

ROC % (Q: . 20 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: . 20 ) + Invested Capital (Q: . 20 ))/ count )
= * ( 1 - % )/( ( + )/ )
=/
= %

where

Invested Capital(Q: . 20 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
= - - ( - max(0, - +))
=

Invested Capital(Q: . 20 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
= - - ( - max(0, - +))
=

Note: The Operating Income data used here is one times the annual (. 20) data.

2. Joel Greenblatt's definition of Return on Capital:

Imed Infinity Medical LP's annualized ROC (Joel Greenblatt) % for the quarter that ended in . 20 is calculated as:

ROC (Joel Greenblatt) %(Q: . 20 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: . 20  Q: . 20
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=/( ( ( + max(, 0)) + ( + max(, 0)) )/ )
=/( ( + )/ )
=/
= %

where Working Capital is:

Working Capital(Q: . 20 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=( + + ) - ( + + )
=

Working Capital(Q: . 20 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=( + + ) - ( + + )
=

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (. 20) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Imed Infinity Medical LP's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: . 20 )
=/6.047
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imed Infinity Medical LP EBIT Related Terms

Imed Infinity Medical LP EBIT Historical Data

* Premium members only.

The historical data trend for Imed Infinity Medical LP's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imed Infinity Medical LP EBIT Chart

Imed Infinity Medical LP Annual Data
Trend
EBIT

Imed Infinity Medical LP Semi-Annual Data
EBIT

XTAE:IMED vs VEEV, BTSG, HQY: EBIT Comparison

For the Health Information Services subindustry, Imed Infinity Medical LP's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Imed Infinity Medical LP EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Imed Infinity Medical LP's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Imed Infinity Medical LP's EV-to-EBIT falls into.


XTAE:IMED
18GF Score
Imed Infinity Medical LP XTAE:IMED
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Imed Infinity Medical LP EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in . 20 was ₪ Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₪ Mil mean?
Imed Infinity Medical LP (XTAE:IMED) has a EBIT of ₪ Mil as of . 20. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Imed Infinity Medical LP.
Is Imed Infinity Medical LP's EBIT too high?
Imed Infinity Medical LP's current EBIT is ₪ Mil. Overall, Imed Infinity Medical LP has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Imed Infinity Medical LP's EBIT compare to VEEV and BTSG?
Imed Infinity Medical LP's EBIT of ₪ Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Imed Infinity Medical LP. Imed Infinity Medical LP's current EBIT is ₪ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imed Infinity Medical LP stock overvalued right now?
Imed Infinity Medical LP (XTAE:IMED) has a current EBIT of ₪ Mil. The current EBIT is ₪ Mil. Imed Infinity Medical LP's overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Imed Infinity Medical LP (XTAE:IMED), the current EBIT is ₪ Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Imed Infinity Medical LP Business Description

Address Azrieli Center, Menachem Begin 132, Triangle Tower 42th Floor, Tel Aviv, ISR, 6701101
Imed Infinity Medical LP is engaged in the business of investing in digital health businesses.
18GF Score

Get the complete analysis for XTAE:IMED

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪0.89
Price